IQM Secures €50M Financing to Accelerate Global Growth
€50 million financing package from funds and accounts managed by BlackRock will support IQM to scale operations, accelerate product development, and strengthen... Read more.
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations
COURBEVOIE, France–(BUSINESS WIRE)–Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch... Read more.
Infinitas Launches Aureon Capital to Open Private Markets to Public Investors
Targeting an initial portfolio of +$100 million Plans to seek a Nasdaq Stockholm listing BASEL, Switzerland–(BUSINESS WIRE)–Infinitas Capital, the Swiss... Read more.
Infinitas Launches Aureon Capital to Open Private Markets to Public Investors
Targeting an initial portfolio of +$100 million Plans to seek a Nasdaq Stockholm listing BASEL, Switzerland–(BUSINESS WIRE)–Infinitas Capital, the Swiss... Read more.
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The Company Wrapped up Its First Month of Robotics Deliveries as It Marches Forward Towards Its 200-unit Delivery Target for the First Delivery Quarter
FFAI will hold its fourth quarter and fiscal year 2025 earnings call and release its Q4 2025 and full-year financial results on April 1 at 7:30 a.m. Beijing Time... Read more.
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The Company Wrapped up Its First Month of Robotics Deliveries as It Marches Forward Towards Its 200-unit Delivery Target for the First Delivery Quarter
FFAI will hold its fourth quarter and fiscal year 2025 earnings call and release its Q4 2025 and full-year financial results on April 1 at 7:30 a.m. Beijing Time... Read more.
Faraday Future to Report Its Fourth Quarter and Full Year 2025 Financial Results and Host an Investor Call on March 31, 2026
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based... Read more.
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ TOKYO–(BUSINESS... Read more.
Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Trial met its primary endpoint, demonstrating clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract (LVOT) gradient... Read more.
Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR™ (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
Merck’s WINREVAIR met primary endpoint of change in pulmonary vascular resistance (PVR), significantly improving the ability of blood to flow through the lungs... Read more.